A novel implantable electromechanical ventricular assist device. First acute animal testing.
A novel ventricular assist device (HIA-EMLVAD-AT1, Helmholtz Institute Aachen-Electromechanical Left Ventricular Assist Device-Animal Test Version 1), driven by a uniformly and unidirectionally rotating actuator and a patented hypocycloidic pusherplate displacement gear unit, was developed and tested in an acute animal experiment. The excellent free filling behavior of the pump chamber with a stroke volume of 65 ml is obtained by a 2:3 ejection-filling time relationship. The uniform motor rotation facilitates simple sensorless pre and afterload detection by motor current analysis. In contrast to common apical cannulation, the inlet cannula was placed via the left atrium through the mitral valve into the left ventricle. This connection mode is preferable for left ventricular recovery and preservation. Left atrial, left ventricular, and aortic pressure curves, as well as pulmonary artery flow data, were obtained. The data show very effective unloading of the natural ventricle and demonstrate the feasibility of this novel assist device. Directions for further improvement of technical features were also identified.
Kaufmann
R
R
Helmholtz Institute for Biomedical Engineering, RWTH Aachen, Germany.
Rakhorst
G
G
Mihaylov
D
D
Elstrodt
J
J
Nix
C
C
Reul
H
H
Rau
G
G
D000818:Animals; D002417:Cattle; D005240:Feasibility Studies; D006339:Heart Rate; D006353:Heart-Assist Devices; D006454:Hemoglobins / Q000032:analysis; D006461:Hemolysis; D008943:Mitral Valve / Q000502:physiology / Q000601:surgery; D013318:Stroke Volume / Q000502:physiology*
D006454:Hemoglobins